Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock Post author:Sam Post published:May 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bay Area???s BioMarin Expands With The World's ???First and Largest??? Gene Therapy Manufacturing Plant August 7, 2017 FDA Greenlights New Treatment for Multi-Drug Resistant HIV-1 March 6, 2018 Iovance Biotherapeutics Appoints As Chief Financial Officer August 8, 2017
Bay Area???s BioMarin Expands With The World's ???First and Largest??? Gene Therapy Manufacturing Plant August 7, 2017